Kenneth Hoberman

Insider Reports History

Location
New York, NY
Signature
/s/ Kenneth Hoberman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Hoberman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TG THERAPEUTICS, INC. Director Common Stock 280K $9.33M $33.37 12 Jun 2025 Direct
Nuvectis Pharma, Inc. Director Common Stock 133K $1.12M $8.43 12 Jun 2025 Direct

Insider Reports Filed by Kenneth Hoberman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TGTX TG THERAPEUTICS, INC. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 17:46
NVCT Nuvectis Pharma, Inc. 12 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:30
TGTX TG THERAPEUTICS, INC. 19 Jun 2024 1 $0 4 Director 20 Jun 2024, 18:05
NVCT Nuvectis Pharma, Inc. 13 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:22
TGTX TG THERAPEUTICS, INC. 28 Sep 2023 1 $0 4 Director 29 Sep 2023, 18:01
NVCT Nuvectis Pharma, Inc. 16 Jun 2023 1 $0 4 Director 20 Jun 2023, 08:15
TGTX TG THERAPEUTICS, INC. 20 Jul 2022 1 $0 4 Director 22 Jul 2022, 16:31
NVCT Nuvectis Pharma, Inc. 12 May 2022 1 $104K 4 Director 16 May 2022, 08:33
NVCT Nuvectis Pharma, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 16:47
NVCT Nuvectis Pharma, Inc. 08 Feb 2022 0 $0 3 Director 08 Feb 2022, 07:29
TGTX TG THERAPEUTICS, INC. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 18:25